Building Confidence with Translational Tools to Predict Efficacy Before the Clinic
Time: 11:30 am
day: Conference Day One
Details:
- Explore how advanced preclinical tools, including immune-fibrotic feedback loops, and disease-relevant models, can derisk antifibrotic opportunities ahead of clinical trials
- Discuss how to move beyond molecular engagement and albuminuria to demonstrate functional and structural changes predictive of long-term efficacy in fibrosis
- Examine how applying clinical insights from the renal space are informing better antifibrotic strategies for Phase 2 readiness
